NCT02255968View on ClinicalTrials.gov

Evaluation of the Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of EDP-788

PHASE1TerminatedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Healthy
Interventions
DRUG

EDP-788

EDP-788 Capsules. All interventions are given as multiple doses.

DRUG

Placebo

Matching placebo capsules. All interventions are given as multiple doses

Trial Locations (1)

78744

PPD Phase 1 Clinic, Austin

Sponsors
All Listed Sponsors
lead

Enanta Pharmaceuticals, Inc

INDUSTRY

NCT02255968 - Evaluation of the Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of EDP-788 | Biotech Hunter | Biotech Hunter